º»¹® ¹Ù·Î°¡±â

·Î±×ÀÎ ¹Ù·Î°¡±â


  • 2026 °øÃ¤

¹ÙÀÌ¿ÀŬ·Ð(ÁÖ) ±â¾÷Á¤º¸

¹ÙÀÌ¿ÀŬ·Ð(ÁÖ)

°ü½É±â¾÷ Ãß°¡Çϰí ä¿ë¼Ò½Ä ¹Þ±â

  • »ý¸í°øÇаü·Ã ¿¬±¸½Ã¾à,±âÀÚÀç,Àåºñ¼öÀÔ
  • ´ëÇ¥ÀÚÀÓÀç±Ù
  • ¼³¸³ÀÏ2000³â 8¿ù 21ÀÏ
  • ¸ÅÃâ¾× 184¾ï 3,412¸¸¿ø (2024)
  • »ç¿ø¼ö 26 ¸í ÀçÁ÷Áß
  • Æò±Õ¿¬ºÀ5,043¸¸¿ø
  • ÀÚº»±Ý 5,000¸¸¿ø

ȸ»ç¼Ò°³

ȸ»ç¼Ò°³

Àü¼¼°è 15°³»ý¸í°øÇÐ °ü·Ã ±â¾÷ÀÇ Çѱ¹´ë¸®Á¡À¸·Î½á ±¹³» °¢¿¬±¸¼Ò¹× ±â¾÷ü ±¹¿µ±â°ü, ´ëÇб³ ¿¬±¸¼Ò¸¦ °Å·¡Ã³·Î µÐ ±â¾÷·Î¼­ ¹Ì·¡¸¦ ÇâÇØ Ç×»ó ¹ßÀüÀ» µµ¸ðÇÏ´Â ±â¾÷ÀÔ´Ï´Ù.

´ç»ç´Â Ã¥ÀÓ°ú ½Å·Ú¸¦ ¹ÙÅÁÀ¸·Î »ý¸í°øÇÐ ¼­ºñ½º¿¡ ÃÖ¼±À» ´ÙÇÑ´Ù´Â °æ¿µÀÌ³ä ¾Æ·¡ ºÐÀÚ ¼¼Æ÷ »ý¹°ÇÐ, ¸é¿ªÇÐ, ±âŸ »ý¹°ÇÐ °ü·Ã ºÐ¾ß¸¦ Æ÷ÇÔÇÏ¿© »ý¸í°øÇÐ ÀüºÐ¾ß °ü·ÃµÈ Àü¼¼°è ½Ã¾à, ±â±â¸¦ Àü¹®ÀûÀ¸·Î °ø±ÞÇϰí ÀÖ´Â ±â¾÷ÀÔ´Ï´Ù.

2000 ³â ¼³¸³ÀÌÈÄ Àü¼¼°è 15¿©°³ »ý¸í°øÇбâ¾÷ÀÇ µ¶Á¡ ´ë¸®Á¡¹× ´ë¸®Á¡À¸·Î½á 2003,2004,2005 ³â »ý¸í°øÇаü·Ã ±¹³» ÃÖ´ëÇÐȸÀÎ ºÐÀÚ¼¼Æ÷ »ý¹°ÇÐȸ¿¡ ºÎ½ºÀü½Ã½Ç ÇÐȸ Âü¼±(ÄÚ¿¢½º,±³À°¹®È­È¸°ü)

ÀÎÀç»ó

±àÁ¤ÀûÀλç°í

¿¬Çõ

2000. ¼³¸³
2001. AG Scientific INC Çѱ¹ÃѴ븮Á¡ ü°á(USA)
2002. Deltabiolabs, LLC Çѱ¹ÃѴ븮Á¡ ü°á
    Cytimmune Çѱ¹ÃѴ븮Á¡ ü°á
    Virogen co Çѱ¹ÃѴ븮Á¡ ü°á
    NEXINS RESEARCH Çѱ¹ÃѴ븮Á¡ ü°á
2003. AUSTRABIOLOGICALS Çѱ¹ÃѴ븮Á¡ ü°á
    QUANTUM DOT CO Çѱ¹ÃѴ븮Á¡ ü°á
    NOVUS BIOLOGICALS Çѱ¹ÃѴ븮Á¡ ü°á
    BIOLEGEND, INC Çѱ¹ÃѴ븮Á¡ ü°á
2004. PHOSPHOSOLUTIONS, INC Çѱ¹ÃѴ븮Á¡ ü°á
2005. DUALSYSTEMS BIOTECH AG
    US-BIOMAX,INC
    PROSPEC-TANY TECHNOGENE LTD Çѱ¹ÃѴ븮Á¡ ü°á
2006,2007,2008,2009 ³â »ý¸í°øÇÐÇÐȸ Àü½ÃºÎ½º Âü°¡.(ÄÚ¿¢½º,±³À°¹®È­È¸°ü)
2008 ¼¼°è 3´ë Ç×üȸ»ç biolegend »ç(USA) Çѱ¹ µ¶Á¡ ´ë¸®Á¡ ü°á

À繫ÇöȲ

ÀÚº»ÃѰè¸ÅÃâ¾×¼øÀÌÀͰá»êÀÏ
160¾ï 2,183¸¸¿ø 184¾ï 3,412¸¸¿ø 31¾ï 1,712¸¸¿ø2024.12.31

´ÜÀ§: ¹é¸¸¿ø

°á»ê ³âµµÀÚº»ÃѰè¸ÅÃâ¾×¼øÀÌÀÍ
2024 160¾ï 2,183¸¸¿ø ¡è 184¾ï 3,412¸¸¿ø ¡é 31¾ï 1,712¸¸¿ø ¡é
2023 129¾ï 470¸¸¿ø ¡è 186¾ï 778¸¸¿ø ¡è 35¾ï 2,315¸¸¿ø ¡è
2018 27¾ï 8,656¸¸¿ø 68¾ï 3,157¸¸¿ø 8¾ï 993¸¸¿ø

Á¤º¸Á¦°ø: ³ªÀ̽ºµð¿£ºñ

±â¾÷À§Ä¡

µ¿ÀÏ ±â¾÷ÀÌ¶óµµ Å¸Áö¿ª ä¿ëÀÇ °æ¿ì, ȸ»ç ÁÖ¼Ò¿Í Àα٠ÁöÇÏö Á¤º¸°¡ »óÀÌÇÒ ¼ö ÀÖ½À´Ï´Ù.